Business Description
Summit Therapeutics is a biopharmaceutical company founded in 2003 and based in Miami, Florida, focused on developing medicines that work better for patients, doctors, and families. Its main drug candidate, ivonescimab, is a next-generation cancer treatment being tested in late-stage clinical trials for lung and colorectal cancers. The company sells its products across North America, Europe, Japan, Latin America, the Middle East, and Africa.
